Infection of EBV-genome-negative and -positive human lymphoblastoid cell lines with biologically different preparations of EBV
- PMID: 4376804
- DOI: 10.1159/000149760
Infection of EBV-genome-negative and -positive human lymphoblastoid cell lines with biologically different preparations of EBV
Abstract
Epstein-Barr virus (EBV) derived from the B95-8 line has transforming activity for cord blood cells, whereas virus derived from the P3HR-1 line lacks such activity. When the two viral preparations were compared for their ability to infect the same EBV-genome-negative lymphoblastoid cell line, BJA-B, they induced approximately the same number of EBV-determined nuclear antigen (EBNA)-positive cells. EBNA is compatibile with continued cell proliferation. No early antigen (EA)-positive cells appeared in the B95-8 virus-infected cultures, whereas P3HR-1 virus-infected cells went on to express EA. EA signals the entry of the cell into the lytic cycle. No late viral antigen (VCA) appeared and, as a consequence, the P3HR-1 virus infection became abortive. In contrast, the EBNA-positive cells induced by the B95-8 virus continued to divide over several weeks. These findings show that different EBV isolates may differ in their biological activity, probably due to their having different degrees of viral dependence on restrictive host cell controls.
Similar articles
-
An EBV-genome-negative cell line established from an American Burkitt lymphoma; receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection.Intervirology. 1975;5(6):319-34. doi: 10.1159/000149930. Intervirology. 1975. PMID: 181343
-
Primary EBV infection of human umbilical cord lymphocytes and EBV genome-negative lymphoblastoid cell lines (BJAB and Ramos).Auris Nasus Larynx. 1986;13(3):199-205. doi: 10.1016/s0385-8146(86)80016-5. Auris Nasus Larynx. 1986. PMID: 3036055
-
Establishment and characterization of an Epstein-Barr virus (EBC)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma.Biomedicine. 1975 Jul;22(4):276-84. Biomedicine. 1975. PMID: 179629
-
High Epstein-Barr virus (EBV) susceptibility of both lymphoblastoid and lymphoma cell lines derived from a Japanese patient with EBV genome-positive Burkitt's lymphoma.Tohoku J Exp Med. 1993 Jun;170(2):71-9. doi: 10.1620/tjem.170.71. Tohoku J Exp Med. 1993. PMID: 8266328
-
Epstein-Barr virus (EBV), lymphocytes and transformation.J Cancer Res Clin Oncol. 1983;106(1):1-11. doi: 10.1007/BF00399890. J Cancer Res Clin Oncol. 1983. PMID: 6309856 Free PMC article. Review. No abstract available.
Cited by
-
Discordance of Epstein-Barr Virus (EBV) specific humoral and cellular immunity in patients with malignant lymphomas: elevated antibody titres and lowered in vitro lymphocyte reactivity.Clin Exp Immunol. 1978 Dec;34(3):338-46. Clin Exp Immunol. 1978. PMID: 217561 Free PMC article.
-
Intercellular adhesion molecule-1 expression on human corneal epithelial outgrowth from limbal explant in culture.Br J Ophthalmol. 2003 Feb;87(2):203-7. doi: 10.1136/bjo.87.2.203. Br J Ophthalmol. 2003. PMID: 12543752 Free PMC article.
-
Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV.J Virol. 1994 Sep;68(9):6069-73. doi: 10.1128/JVI.68.9.6069-6073.1994. J Virol. 1994. PMID: 8057484 Free PMC article.
-
Effects of DNA synthesis inhibitors on early antigen expression following primary infection or superinfection by Epstein-Barr virus.Arch Virol. 1983;77(1):13-25. doi: 10.1007/BF01314860. Arch Virol. 1983. PMID: 6312934
-
Up to 100-fold increase of apparent gene expression in the presence of Epstein-Barr virus oriP sequences and EBNA1: implications of the nuclear import of plasmids.J Virol. 1998 Jul;72(7):6181-5. doi: 10.1128/JVI.72.7.6181-6185.1998. J Virol. 1998. PMID: 9621086 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources